Company profile
Avalo Therapeutics, Inc. Insider Trading
AVTXEvery SEC Form 4 insider trading filing for Avalo Therapeutics, Inc. (AVTX) since April 2023 — open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?
- Exchange
- Nasdaq
- Sector
- Pharmaceutical Preparations
- CIK
- 0001534120
- Filings
- 123
- Insiders
- 21
- Last filing
- 2026-08-18
Activity summary
Recent insider activity is bullish. Over the last 30 days, 4 insiders purchased shares versus 3 sales. Buying was led by Sullivan Christopher Ryan.
Three year balance
Buy and sell value by quarter, Q2 23 to Q3 26. Avalo Therapeutics, Inc. insiders are net sellers across the period shown.
Bars below the rule are sales, above are purchases. Largest quarter on the chart is $6.0M.
90 day insight
Over the last 90 days, Avalo Therapeutics, Inc. insiders bought $369K (14 transactions) and sold $787K (7 transactions).
- Most active insider: Doyle Mittie with 21 transactions totaling $296K.
- Largest single sale: $753K by Sullivan Christopher Ryan on Aug 17, 2026.
- 50% of recent sales were pre-scheduled 10b5-1 trades — typically less informative than open-market activity.
Activity skews bullish — buys outpace sales.
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 18, 2026 | Sullivan Christopher Ryan | AVTX | Option Exercise | 31,031 | — | — |
| Aug 18, 2026 | Sullivan Christopher Ryan | AVTX | Sale | 31,031 | $20.05 | $622K |
| Aug 18, 2026 | Sullivan Christopher Ryan | AVTX | Option Exercise | 31,031 | $9.88 | $307K |
| Aug 17, 2026 | Sullivan Christopher Ryan | AVTX | Sale | 3,749 | $19.94 | $75K |
| Aug 17, 2026 | Sullivan Christopher Ryan | AVTX | Option Exercise10b5 | 37,945 | $9.88 | $375K |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Query this yourself
The same rows, over the API.
curl "https://api.form4api.com/v1/transactions?ticker=AVTX" \
-H "X-Api-Key: $KEY"Top insiders
By total value filed.
Institutional Ownership
Top 13F-HR holders of Avalo Therapeutics, Inc. as of 2026-06-30
Data source: quarterly 13F-HR filings — institutional holders report positions within 45 days of quarter end. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →